NAUTIKA1 study: Preliminary efficacy and safety data with neoadjuvant alectinib in patients with stage IB-III ALK+ NSCLC Meeting Abstract
| Authors: | Lee, J. M.; Toloza, E. M.; Pass, H. I.; Johnson, B. E.; Heymach, J. V.; Sholl, L.; Saqi, A.; Travis, W. D.; Wistuba, I.; Lin, J.; Kris, M. G.; Spira, A. I.; Shu, C. A.; Saltos, A. N.; Ding, B.; Schulze, K.; Zhu, Q.; Ngiam, C.; Bara, I.; Chaft, J. E. |
| Abstract Title: | NAUTIKA1 study: Preliminary efficacy and safety data with neoadjuvant alectinib in patients with stage IB-III ALK+ NSCLC |
| Meeting Title: | 2023 World Conference on Lung Cancer |
| Keywords: | neoadjuvant; alectinib; local-regional nsclc |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 18 |
| Issue: | 11 Suppl. |
| Meeting Dates: | 2023 Sep 9-12 |
| Meeting Location: | Singapore |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-11-01 |
| Start Page: | S297 |
| End Page: | S298 |
| Language: | English |
| ACCESSION: | WOS:001098831600493 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2023.09.511 |
| Notes: | Meeting Abstract: P2.01-06 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
